Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling.
Deroche L, Aranzana-Climent V, Rozenholc A, Prouvensier L, Darnaud L, Grégoire N, Marchand S, Ploy M-C, François B, Couet W, Barraud O, Buyck JM. Deroche L, et al. Among authors: barraud o. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0048023. doi: 10.1128/aac.00480-23. Epub 2023 Sep 11. Antimicrob Agents Chemother. 2023. PMID: 37695298 Free PMC article.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study Group. Chastre J, et al. Among authors: barraud o. Crit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9. Crit Care. 2022. PMID: 36380312 Free PMC article. Clinical Trial.
Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales.
Jousset AB, Bernabeu S, Emeraud C, Bonnin RA, Lomont A, Zahar JR, Merens A, Isnard C, Soismier N, Farfour E, Fihman V, Yin N, Barraud O, Jacquier H, Ranc AG, Laurent F, Corvec S, d'Epenoux LR, Bille E, Degand N, Plouzeau C, Guillard T, Cattoir V, Mizrahi A, Grillon A, Janvier F, Brun CL, Amara M, Bastide M, Lemonnier A, Dortet L; GMC-study Group. Jousset AB, et al. Among authors: barraud o. J Glob Antimicrob Resist. 2023 Mar;32:78-84. doi: 10.1016/j.jgar.2023.01.003. Epub 2023 Jan 26. J Glob Antimicrob Resist. 2023. PMID: 36708769 Free article.
Antibiotic Resistance Acquisition in the First Week of Life.
Barraud O, Peyre M, Couvé-Deacon E, Chainier D, Bahans C, Guigonis V, Ploy MC, Bedu A, Garnier F. Barraud O, et al. Front Microbiol. 2018 Jul 4;9:1467. doi: 10.3389/fmicb.2018.01467. eCollection 2018. Front Microbiol. 2018. PMID: 30022973 Free PMC article.
Proteae: a reservoir of class 2 integrons?
Mendes Moreira A, Couvé-Deacon E, Bousquet P, Chainier D, Jové T, Ploy MC, Barraud O. Mendes Moreira A, et al. Among authors: barraud o. J Antimicrob Chemother. 2019 Jun 1;74(6):1560-1562. doi: 10.1093/jac/dkz079. J Antimicrob Chemother. 2019. PMID: 30805633
90 results